Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04344015 · ClinicalTrials.gov registry record · NA
COVID-19 Plasma Collection
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT04344015 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 206 participants.
The verdict
NCT04344015, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
Patients who are severely ill with COVID-19 may benefit from receiving plasma infusions from donors who have recovered from the disease and are proven to no longer be infected. Efforts to initiate the collection and infusion of these products to high risk patients have been initiated around the world and the FDA has recently provided information about how this could be accomplished. As the Jefferson Blood Donor Center already has processes to collect, test and process blood, investigators are planning to make efforts to collect plasma for this use should it be necessary. The purpose of this study is to describe the process for identifying and collecting convalescent plasma from donors previously infected with the virus. The research portion on top of this standard blood product collection will the process of identification of subjects and processes by which blood products are processed in this special population. This protocol does not involve the administration of blood products to patients with COVID-19 infection.
Interventions
- OTHER Plasma Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2020-04-13 |
| Est. Completion | 2020-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04344015
The ClinicalTrials.gov registry entry for NCT04344015 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma Donation is the first listed.
NCT04344015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04344015 about?
NCT04344015 is a clinical study titled "COVID-19 Plasma Collection". Patients who are severely ill with COVID-19 may benefit from receiving plasma infusions from donors who have recovered from the disease and are proven to no longer be infected. Efforts to initiate the collection and infusion of these products to high risk patients have been initiated around the worl...
What is the current status of trial NCT04344015?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2020-04-13. Estimated completion is 2020-06-02.
What interventions are being tested in trial NCT04344015?
The interventions under investigation include: Plasma Donation (OTHER).
Who is sponsoring clinical trial NCT04344015?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.